MERTK and neoplasm: These changes in downstream apoptotic signaling promote tumor cell survival and inhibition of MERTK using shRNA or small molecule inhibitors induced apoptosis and inhibited colony formation in AML and ALL cell lines and AML patient samples [24,53,54].